Home > Insider Trading > Filing (0000908662-14-000104)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
907562	Dyax Corp	DYAX	Services-Commercial Physical & Biological Research (8731)	043053198

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1226283	A Burt Adelman	C/O Dyax Corp. 55 Network Drive Burlington MA 01803-2756	Cmo & Evp, R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-02-27	37,500	$10.20	37,500	No	4	A	Direct
Common Stock	Acquisiton	2014-03-03	55,000	$1.48	92,500	No	4	M	Direct
Common Stock	Disposition	2014-03-03	55,000	$9.68	37,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2014-02-27	225,000	$0.00	225,000	$10.20
Common Stock	Stock Option (right to buy)	Disposition	2014-03-03	55,000	$0.00	55,000	$1.48

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
225,000		2024-02-27	No	4	A	Direct
295,000		2022-02-24	No	4	M	Direct

Footnotes

The securities reported were granted pursuant to the Issuer's Amended and Restated 1995 Equity Incentive Plan. The award vests in four equal annual installments beginning on March 5, 2015.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $9.37 to $10.22, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within that range.
Such option will become exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equivalent is accumulated).
Such option vests in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, which was February 24, 2012.